(IBDS) iShares iBonds Dec 2027 - Ratings and Ratios
Corporate Bonds, 2027 Maturity, Investment-Grade
Description: IBDS iShares iBonds Dec 2027
The iShares iBonds Dec2027 Term Corporate ETF (IBDS) is an exchange-traded fund that tracks a specific index of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2027. The fund maintains a high level of consistency with its underlying index by investing at least 80% of its assets in the component securities and at least 90% in similar fixed income securities.
From a strategic perspective, IBDS offers a targeted maturity approach, allowing investors to capitalize on a specific segment of the corporate bond market with a defined maturity date. This can be particularly appealing for investors seeking to match their investment horizon with the funds maturity, potentially reducing interest rate risk associated with longer-term or perpetual bonds.
Key performance indicators (KPIs) to monitor for IBDS include its yield to maturity (YTM), which can provide insight into the funds potential return if held until maturity. Additionally, the funds credit quality, as measured by the average credit rating of its holdings, is crucial in assessing the risk of default. The funds duration, a measure of its sensitivity to interest rate changes, is also an important metric, although it will naturally decrease as the fund approaches its maturity date in 2027. Investors should also keep an eye on the funds expense ratio and tracking error relative to its underlying index to ensure that costs are minimized and that the fund is effectively mirroring its target index.
Given the current market conditions, its essential to evaluate IBDS within the context of a broader fixed income strategy, considering factors such as interest rate expectations, credit spreads, and overall economic outlook. As a targeted maturity fund, IBDS can serve as a valuable component in a diversified investment portfolio, offering a relatively predictable income stream and return of principal at maturity, assuming the underlying bonds are held to maturity and do not default.
IBDS ETF Overview
Market Cap in USD | 3,291m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2017-09-12 |
IBDS ETF Ratings
Growth Rating | 59.3% |
Fundamental | - |
Dividend Rating | 72.1% |
Return 12m vs S&P 500 | -12.0% |
Analyst Rating | - |
IBDS Dividends
Dividend Yield 12m | 4.42% |
Yield on Cost 5y | 4.60% |
Annual Growth 5y | 7.44% |
Payout Consistency | 95.1% |
Payout Ratio | % |
IBDS Growth Ratios
Growth Correlation 3m | 97.7% |
Growth Correlation 12m | 95.1% |
Growth Correlation 5y | 17.7% |
CAGR 5y | 5.57% |
CAGR/Max DD 3y | 1.62 |
CAGR/Mean DD 3y | 14.16 |
Sharpe Ratio 12m | -2.15 |
Alpha | 0.02 |
Beta | 0.973 |
Volatility | 1.51% |
Current Volume | 732.8k |
Average Volume 20d | 631.1k |
Stop Loss | 23.6 (-3%) |
Signal | 0.73 |
What is the price of IBDS shares?
Over the past week, the price has changed by +0.12%, over one month by +0.69%, over three months by +1.87% and over the past year by +4.31%.
Is iShares iBonds Dec 2027 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDS is around 22.96 USD . This means that IBDS is currently overvalued and has a potential downside of -5.63%.
Is IBDS a buy, sell or hold?
What are the forecasts/targets for the IBDS price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.9 | 6.3% |
Last update: 2025-09-05 04:46
IBDS Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.62
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.29b USD (3.29b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 3.29b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.29b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(3.29b)/V(0.0) * Re(9.60%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.60% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle